← back to database
Sofinnova Investments is a clinical-stage biopharmaceutical venture firm that partners with entrepreneurs developing transformative medicines. It combines investment experience with drug-development and operating expertise and has approximately $2B in assets under management and committed capital.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$4.6B AUM and committed capital
Investing team
Chris CarpenterExecutive Partner, Private Equity
Eric HsuAnalyst, Private Equity
Jakob DupontExecutive Partner, Private Equity
Jim HealyManaging Partner
Jonathan LeffExecutive Partner, Private Equity
Lars EkmanExecutive Partner, Private Equity
Maha KatabiGeneral Partner
Maha RadhakrishnanExecutive Partner, Private Equity
Mike VanAssociate, Private Equity
Naomi PacalinAssociate, Private Equity